ProKidney
PROK
35 hedge funds and large institutions have $391M invested in ProKidney in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 1 closing their positions.
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
220% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 5
81% more capital invested
Capital invested by funds: $216M → $391M (+$176M)
30% more funds holding
Funds holding: 27 → 35 (+8)
5.09% more ownership
Funds ownership: 51.08% → 56.17% (+5.1%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$42.3M |
| 2 |
Millennium Management
New York
|
+$1.09M |
| 3 |
BlackRock
New York
|
+$1.09M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$729K |
| 5 |
HF
HRT Financial
New York
|
+$687K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$14.2M |
| 2 |
Swiss National Bank
Zurich,
Switzerland
|
-$84.1K |
| 3 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$72K |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$33.2K |
| 5 |
US Bancorp
Minneapolis,
Minnesota
|
-$6.29K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $59K | +$27.4K | +2,571 | +97% |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $50K | +$23.5K | +2,211 | +98% |
|
28
JP Morgan Chase
New York
| $49K | +$9.74K | +915 | +27% |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $12K | +$160 | +15 | +1% |
|
30
Citigroup
New York
| $8.75K | +$64 | +6 | +0.8% |
|
|
SIC
31
Salem Investment Counselors
Winston Salem,
North Carolina
| $5.24K | +$4.93K | +463 | New |
|
|
32
US Bancorp
Minneapolis,
Minnesota
| $4.63K | -$6.29K | -591 | -59% |
|
|
S
33
SignatureFD
Atlanta,
Georgia
| $1.19K | – | – | – |
|
34
Wells Fargo
San Francisco,
California
| $815 | -$75 | -7 | -9% |
|
35
Osaic Holdings
Scottsdale,
Arizona
| $11 | +$11 | +1 | New |
|
|
CLOS
36
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| – | -$72K | -10,500 | Closed |
|
PROK Hedge Fund Activity: Q1 2023 in Review
35 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q1 2023, worth a combined $391M — up 81% from $216M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new PROK positions and 1 closed out — a net gain of 8 holders — while 16 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $42.3M. The largest seller was Morgan Stanley, cutting an estimated $14.2M.
- 35 institutional investors held ProKidney (PROK) as of Q1 2023, up from 27 in Q4 2022.
- Funds reported $391M of ProKidney stock for Q1 2023, up 81% quarter-over-quarter.
- 9 funds opened new ProKidney positions in Q1 2023 and 1 closed out, a net change of +8 holders.
- The largest ProKidney buyer in Q1 2023 was Vanguard Group, an estimated $42.3M added.
- The largest ProKidney seller in Q1 2023 was Morgan Stanley, an estimated $14.2M sold.
Based on aggregated 13F filings for Q1 2023.